Shorter course of treatment may provide better outcome for intermediate-risk prostate cancer

To accurately test the hypothesis of a lower risk of recurrence with hypo fractionated radiotherapy, a new study led by investigators at Brigham and Women’s Hospital published in European Urology Focus, performed a systematic review and meta-analysis, pooling available data, to assess whether an improved risk of recurrence could be demonstrated using hypo fractionated radiotherapy compared with fractionated high dose external beam radiotherapy.
Medial Xpress